Gotham Asset Management Boosts Regeneron Pharmaceuticals Stake

Investment firm increases holdings in biotech company by 211.9% in Q3

Mar. 16, 2026 at 10:39am

Got story updates? Submit your updates here. ›

Gotham Asset Management LLC, a New York-based investment firm, increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 211.9% in the third quarter, according to a recent SEC filing. The firm now owns 84,230 shares of the biopharmaceutical company's stock, worth approximately $47.36 million.

Why it matters

Regeneron Pharmaceuticals is a leading biotech company known for its innovative drug discovery and development capabilities. The significant increase in Gotham Asset Management's stake suggests the investment firm sees strong growth potential in Regeneron's pipeline and future prospects.

The details

According to the 13F filing, Gotham Asset Management purchased an additional 57,225 shares of Regeneron Pharmaceuticals during the third quarter, bringing its total position to 84,230 shares. This represents a 211.9% increase in the firm's holdings of the biotech company's stock.

  • Gotham Asset Management increased its Regeneron Pharmaceuticals stake in the third quarter of 2026.

The players

Gotham Asset Management LLC

A New York-based investment management firm that focuses on alternative investment strategies.

Regeneron Pharmaceuticals, Inc.

A U.S. biotechnology company that focuses on discovering, developing, manufacturing, and commercializing medicines for serious medical conditions.

Got photos? Submit your photos here. ›

The takeaway

Gotham Asset Management's significant increase in its Regeneron Pharmaceuticals stake suggests the investment firm sees strong growth potential in the biotech company's pipeline and future prospects. This move highlights the continued investor interest in Regeneron's innovative drug development capabilities.